Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
TLPH · NASDAQ · Pharmaceutical Preparations
Talphera (TLPH) · oqro.io/stocks/TLPH · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.7852+0.0462 (+6.25%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Feb 12, 2026 · Filed Feb 21, 2026
CEO purchased ~$86K of TLPH shares in the open marketSourceInsider trade · Traded Feb 12, 2026 · Filed Feb 21, 2026
CFO purchased ~$37K of TLPH shares in the open marketSourceInsider trade · Traded Feb 12, 2026 · Filed Feb 21, 2026
Officer purchased ~$28K of TLPH shares in the open marketSourceInsider trade · Traded Feb 12, 2026 · Filed Feb 21, 2026
Officer purchased ~$28K of TLPH shares in the open marketSourceInsider trade · Traded Apr 2, 2025 · Filed Apr 3, 2025
CEO purchased ~$125K of TLPH shares in the open marketSourceInsider trade · Traded Jun 14, 2024 · Filed Feb 26, 2025
Officer purchased ~$5.4K of TLPH shares in the open marketSourceInsider trade · Traded Jun 13, 2024 · Filed Feb 26, 2025
Officer purchased ~$681 of TLPH shares in the open marketSourceInsider trade · Traded Dec 5, 2024 · Filed Dec 6, 2024
CEO purchased ~$3.2K of TLPH shares in the open marketSourceInsider trade · Traded Nov 27, 2024 · Filed Dec 2, 2024
CEO purchased ~$3.6K of TLPH shares in the open marketSourceInsider trade · Traded Dec 2, 2024 · Filed Dec 2, 2024
CFO sold ~$119 of TLPH shares in the open marketSource